Delphinus Medical Technologiesincis A Medical Imaging Company Based In Novimichiganfounded In 2010The Company Specializes In Advanced Breast Cancer Screening Solutionsparticularly For Women With Dense Breast Tissuedelphinus Has Raised $137 11 Million In Fundingdemonstrating Strong Investor Confidence In Its Innovative Technology The Company S Flagship Productthe Softvuea C Ultrasound Tomography Systemutilizes A Unique Circular Triple Acoustic Transducer To Perform Whole Breast Scans Without Radiationthis System Captures 3D Volumetric Data In A Single Scanproviding Detailed Imaging To Help Identify Tissue Abnormalitiesdelphinus Aims To Enhance Diagnostic Accuracy While Ensuring Patient Comfort And Accessibilitymaking It A Valuable Supplemental Tool Alongside Traditional Mammography Under The Leadership Of President And Ceo Scott Awhitedelphinus Has Established Partnershipsincluding A Significant Agreement With Premierinc Which Expands Its Reach To Over 4 400 U Shospitals And Health Systemsthe Company Is Recognized For Its Commitment To Improving Breast Cancer Detection And Has Received Accolades For Its Innovative Technology
